Proteomic analysis of p16ink4a-binding proteins

Elielson Souza-Rodrígues1, Josep M Estanyol, Erica Friedrich-Heineken

  • 1Departament de Biologia Cellular i Anatomia Patològica, Facultat de Medicina, Universitat de Barcelona, Spain.

Proteomics
|October 24, 2007
PubMed

Insights

The p16(ink4a) tumor suppressor protein interacts with new partners, including PCNA, a key DNA replication factor. This interaction inhibits DNA polymerase activity, revealing novel functions beyond cell cycle control.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The p16(ink4a) protein is a crucial tumor suppressor involved in cell cycle control, tumorogenesis, and senescence.
  • Its known function involves inhibiting CDK4 and CDK6 kinases, essential for cell cycle progression.

Purpose of the Study:

  • To identify novel p16(ink4a)-interacting proteins and elucidate new functions of p16(ink4a).

Main Methods:

  • Affinity chromatography using p16(ink4a) coupled to Sepharose 4B.
  • Mass spectrometry (MALDI-TOF) for protein identification.
  • Western blotting, immunoprecipitation, and immunofluorescence for validation.

Main Results:

  • Thirty-one p16(ink4a)-interacting proteins were identified, grouped into functional clusters.
  • Proliferating cell nuclear antigen (PCNA) and minichromosome maintenance protein 6 (MCM6) were identified and validated.
  • p16(ink4a) directly interacts with PCNA, inhibiting its DNA polymerase activity.

Conclusions:

  • p16(ink4a) possesses novel functions beyond cell cycle regulation, including direct interaction with and inhibition of PCNA's polymerase activity.
  • These findings expand our understanding of p16(ink4a)'s role in cellular processes and cancer.

Related Concept Videos